NCT05455918View on ClinicalTrials.gov

Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor

PHASE2RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 26, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2028

Conditions
Pediatric Germ Cell Tumor
Interventions
DRUG

TIP treatment (paclitaxel/ifosfamide/cisplatin)

Paclitaxel 240mg/m2/day D1 (total 240mg/m2) Ifosfamide 1.5g/m2/day D2\~5 (total 6g/m2) Cisplatin 25mg/m2/day D2\~5 (total 100mg/m2)

Trial Locations (1)

Unknown

RECRUITING

Yonsei University Health System, Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER